穴位敷贴联合雾化吸入治疗喉源性咳嗽临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R276.1

基金项目:


Clinical Study on Acupoint Application Combined with Aerosol Inhalation for Laryngeal Cough
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察穴位敷贴联合雾化吸入治疗喉源性咳嗽的疗效及复发情况。方法:选取2023年7月— 2024年4月湖州市南浔区人民医院收治的150例喉源性咳嗽患者,按治疗方式不同分成对照组90例及研究组 60例。对照组采用雾化吸入治疗,研究组采用天突穴和大椎穴穴位敷贴联合雾化吸入治疗。比较2组临床疗 效、不良反应发生率及复发率,比较2 组治疗前后中医证候积分、临床体征评分[咽部黏膜慢性充血积 分(PMCHS)、咽部黏膜水肿积分(PMES)、咽后壁淋巴滤泡增生积分(PLFHS)] 的变化。结果:研究组临 床疗效总有效率为91.67%(55/60),对照组为78.89%(71/90),2组比较,差异有统计学意义(P<0.05)。治 疗后,2组咳嗽、喉咙瘙痒、口咽干燥、喉咙疼痛中医证候积分均较治疗前下降(P<0.05),研究组上述4项 中医证候积分均低于对照组(P<0.05)。治疗后,2 组PMCHS、PMES、PLFHS 评分均较治疗前下降(P< 0.05),研究组PMCHS、PMES、PLFHS评分均低于对照组(P<0.05)。2组不良反应发生率比较,差异无统计 学意义(P>0.05)。研究组复发率为7.27%(4/55),对照组为23.94%(17/71),2组复发率比较,差异有统计 学意义(P<0.05)。结论:穴位敷贴联合雾化吸入治疗喉源性咳嗽疗效较好,能缓解临床症状,缓解咽部充血 水肿、咽后壁淋巴滤泡增生,安全性高,复发风险低。

    Abstract:

    Abstract:Objective:To observe the clinical efficacy of acupoint application combined with aerosol inhalation in the treatment of laryngeal cough and its recurrence. Methods:A total of 150 patients with laryngeal cough diagnosed and treated at Huzhou Nanxun People′s Hospital from July 2023 to April 2024 were selected and divided into the control group (90 cases) and the study group (60 cases) based on different treatment methods. The control group received aerosol inhalation therapy alone, while the study group received acupoint application at Tiantu (RN22) and Dazhui (DU14) points combined with aerosol inhalation. The clinical efficacy, incidence of adverse reactions, and recurrence rate were compared between the two groups. Changes in traditional Chinese medicine syndrome scores and clinical sign scores [Pharyngeal Mucosal Chronic Hyperemia Score (PMCHS) , Pharyngeal Mucosal Edema Score (PMES), Postpharyngeal Lymphatic Follicle Hyperplasia Score (PLFHS)] before and after treatment were compared between the two groups. Results: The total effective rate of clinical efficacy in the study group was 91.67% (55/60),compared to 78.89% (71/90) in the control group,with a statistically significant difference between the two groups (P<0.05). After treatment, traditional Chinese medicine syndrome scores for cough, throat itching, dry mouth and throat,and throat pain decreased in both groups compared to before treatment,and the scores for these four traditional Chinese medicine syndromes in the study group were lower than those in the control group (P<0.05). After treatment, PMCHS, PMES, and PLFHS scores decreased in both groups compared to before treatment (P< 0.05), and the scores in the study group were lower than those in the control group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). The recurrence rate was 7.27% (4/55) in the study group and 23.94% (17/71) in the control group, with a statistically significant difference (P<0.05). Conclusion: Acupoint application combined with aerosol inhalation is effective in treating laryngeal cough, alleviating clinical symptoms, reducing pharyngeal congestion and edema, and improving postpharyngeal lymphatic follicle hyperplasia. It demonstrates higher safety and lower risk of recurrence.

    参考文献
    相似文献
    引证文献
引用本文

和鹏鹏,戴金伟,陈诚,张旭.穴位敷贴联合雾化吸入治疗喉源性咳嗽临床研究[J].新中医,2025,57(23):110-114

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-12
  • 出版日期:
文章二维码